fda warning letters compounded semaglutide october 2025 Medscape | The has approved once-daily oral 25 mg (Wegovy Pill, Novo Nordisk) as the first GLP-1 agonist pill for weight management. ⁠ Compounded GLP-1s: Why doctors worry

The hormonal changes from poor sleep affect metabolism, hunger, and fat storage in ways that partially resist pharmacological intervention

Managing side effects

The clinical work addresses the architectural problem

They must follow United States Pharmacopeia standards for sterile compounding but are not required to register with the FDA or follow the same Current Good Manufacturing Practices (cGMP) that pharmaceutical manufacturers must meet

Access usually requires a prescription from your doctor and is subject to local availability

Some of the ingredients you might see are probiotic strains like Akkermansia muciniphila, Clostridium butyricum, and Bifidobacterium infantis for supporting your gut health